Cognetivity Neurosciences Ltd (CGNSF) Predicción del precio de las acciones

Cognetivity Neurosciences Ltd. operates as a technology company. The company is headquartered in Vancouver, British Columbia. The firm has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. The company is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.